week one semaglutide 1 of my (GLP-1) journey is done! 💉✨, Did I lose 2 kg in week? ❌, No., I lost 600 grams. ✅, And I'm actually happy with that., No fake transformations. No unrealistic expectations. ✨ 𝐓𝐡𝐢𝐬 𝐖𝐞𝐞𝐤'𝐬 𝐌𝐮𝐬𝐭-𝐑𝐞𝐚𝐝 𝐢𝐧

Force Factor Super GLP-1 Support does not contain GLP-1 or synthetic GLP-1 and is not designed to replace GLP-1 medication. Consult a healthcare professional before discontinuing use of GLP-1 medication. *In a clinical study by Ribeiro et al. (2019), adults with elevated blood sugar levels taking 200mg of Eriomin per day saw a significant improvement of 15.6% in GLP-1 levels by week 12, compared to a 0.2% increase in the placebo group. **In a clinical study by Kaats et al. (1996), subjects who took Chromax Chromium Picolinate showed an improvement in body composition scores, percent body fat, and weight compared to placebo, in conjunction with a regular diet and exercise program. All ingredient amounts listed are per serving. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease

A 2026 review in Drugs lays out the clinical tension clearly: maternal obesity + excess gestational weight gain drive major short- and long-term risks for both mother and baby, while lifestyle-only strategies often deliver modest resultscreating a real unmet need

Can I take all five together

Recent Findings Intentional weight loss via semaglutide among persons with heart failure and preserved ejection fraction and obesity significantly improves weight loss and health status as assessed by the KCCQ-CSS score and is associated with improvements in 6-min walk test

Very well written and comprehensive comparison Very informative table for RWE studies comparing tirzepoatide vs semaglutide The only addition/correction I would make is that both tirzepatide and semaglutide have trials in patients with HFpEF and both with very positive results #tirzepatide #semaglutide #obesity #type2diabetes #cardiovascularcomplications #rwe

Less common Full Blood Count Markers (marked with*symbol) are not reported in Capillary/Home kit samples due to their instability